Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Broncho-munal in Acute Uncomplicated Respiratory Tract Infections
NCT05588804Phase 3Completed
- Sponsor
- Sandoz
- Start
- Nov 2022
- Primary completion
- Dec 2022
- Modality
- Microbiome Therapeutics, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of bacterial lysate in Airways Infection, sponsored by Sandoz. Started Nov 2022; status: completed.
02
Drugs
bacterial lysate
03
Conditions
Airways Infection
Beyond the preview
Go deeper on NCT05588804.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05588804.